Stone Woo

NEW EPISODE ALERT!! "How Can We Make This???" Episode #2 is OUT NOW!! Join Aidan Looby, Eleanor Landwehr, and Prof. Jeff Johnson as we try to answer this question for Phlegmadine B! Link: youtu.be/W_aum9sNqig?si… @aplooby28 @EleanorMLandwe1 @JohnsonGroup

#Totalsynthesis of twenty-five picrotoxanes by virtual library selection by Chunyu Li and Ryan Shenvi @Shenvi_Lab at @scrippsresearch chemrxiv.org/engage/chemrxi…

In this paper, 3rd year graduate student 李春雨 (Chunyu Li) synthesized 25 natural products (!!) using a method of in silico library selection. Chunyu is a new type of student in our lab, having seamlessly blended calculation and synthesis. Take a look: tinyurl.com/mryjxh2w

In a new @ScienceMagazine study, the @Shenvi_Lab, with @BaranLabReads, converted feedstock chemicals into quaternary carbons with a single, inexpensive iron catalyst that could lead to cheaper and easier production of drug molecules. More: ow.ly/faks50R9E94

Shuttle HAT: A simple solution for all your MHAT needs. No more wasting silanes and/or oxidants to generate your Co–H – Now all you need is a C–H bond. chemrxiv.org/engage/chemrxi…

Scripps Research chemists Ryan Shenvi and Guanghu Tong in the @Shenvi_Lab have modified the traditional poison picrotoxinin, significantly improving its stability and safety for potential neurological drugs, pesticides and anti-parasite treatments. ow.ly/wg3n50QkPa8

Join a group of exceptional Ph.D. students and postdoctoral scholars from around the world to take the next steps in your leadership journey. Apply for the 2024 #CASFutureLeaders program by Sunday, January 28, 2024! ow.ly/hUJ550QcwFi

#2: Had a blast collaborating with @BaranLabReads. Felt like old times. tinyurl.com/7heyrvka We report a single catalyst that quaternizes 3° radicals derived from RAEs or olefins. Very simple conditions: iron, reductant, base.

Hi all, I am running for the member-at-large position in this years Division of Organic Chemistry Elections! If you’re a member of the DOC, check out the ballot to find short biographies and personal statements for each exceptional candidate. I encourage you to vote!

The 2023 @ScrippsGradPrgm Organometallics Course is live. All course materials available on the web: englelab.com/organometallic… All lectures on @YouTube: m.youtube.com/watch?v=65XmR_…

Happy to share this total synthesis: not the end, but only the beginning. pubs.acs.org/doi/10.1021/ja…

Showcasing the power of working together, our collaborative paper in @J_A_C_S with @GroupItemm details how #bimetallic #cooperativity between #lithium and #nickel enables the cross-coupling of aryl ethers! @EvaHeviaGroup @DCBPunibern pubs.acs.org/doi/10.1021/ja…

Very excited to announce a new 3 year post doc position in my lab @newgroupchem, working on the synthesis and application of responsive probes for biological systems, funded by @ARC_CIPPS. Visa sponsorship available. usyd.wd3.myworkdayjobs.com/en-US/USYD_EXT… @SydneyChemistry Please RT.

Thirty-five graduate students and postdoctoral researchers make up the CAS Future Leaders class of 2023. Participants in this program gain leadership skills and learn about the chemical information industry. fal.cn/3Apkc

Today, CAS kicks off the 2023 #CASFutureLeaders program, welcoming a new class of early-career scientists from around the world. Participants will learn leadership, present their research at #ACSFall2023, & connect to a global network of fellow scientists. ow.ly/1crP50PtX4J

Loved being able to finally meet fellow #CASFutureLeaders tonight in Columbus, Ohio! Looking forward to the two weeks ahead 🙌🏽

Kicking off #CASFutureLeaders week at @HiltonColumbus! Excited to get to know this year’s class.

@citizenSTEM Meet @stwooone #CASFutureLeaders #stone-woo" target="_blank" rel="nofollow noopener">cas.org/about/futurele…

Would you like to join this talented group of scientists working on the medicinal chemistry of natural products involved in pain and addiction? Good news, you can!!! We are hiring a postdoc: uic.csod.com/ux/ats/careers… Please re-tweet and help spread the word!

The drug navacaprant (NMRA-140), invented by Scripps Research’s profs. Hugh Rosen and Ed Roberts, will be entering a Phase 3 pivotal clinical program to evaluate its safety and efficacy for the treatment of major depressive disorder (MDD). scripps.edu/news-and-event… #depression